Table 1 Baseline characteristics according to diagnosis and nutritional therapy
Fasting | Mediterranean Diet | |||
|---|---|---|---|---|
FM | RA | FM | RA | |
N | 21 | 9 | 14 | 7 |
Age, y | 52.0 ± 10.0 | 57.7 ± 6.5 | 51.6 ± 13.3 | 49.4 ± 14.3 |
Female sex (n/%) | 19 (90%) | 9 (100%) | 13 (93%) | 7 (100%) |
BMI, kg/m2 | 26.9 ± 3.7 | 28.8 ± 6.9 | 25.2 ± 3.8 | 23.2 ± 4.3 |
Disease Activity | ||||
RA (DAS 28) | 62.6 ± 12.3 | 59.6 ± 12.3 | ||
FM (VAS) | 5.1 ± 1.5 | 5.3 ± 1.9 | ||
Medication, n (%) | ||||
NSAIDs | 10 (48) | 7 (78) | 7 (50) | 4 (57) |
Other Analgetics* | 5 (24) | 1 (11) | 2 (14) | 3 (43) |
DMARDs | 0 (0) | 5 (56) | 0 (0) | 2 (29) |
Corticosteroids | 0 (0) | 3 (33) | 0 (0) | 3 (43) |
Nutritional intake, Mediterranean Diet score (7–35)** | 22.3 ± 2.5 | 24.3 ± 3.5 | 23.2 ± 3.4 | 25.9 ± 3.1 |